| abstract |
The present invention relates to an aspartic acid protease inhibitor of formula (I) or a pharmaceutically acceptable salt thereof:n n n n n n n n The invention also relates to a pharmaceutical composition comprising an aspartic acid protease inhibitor of formula (I). The present invention also provides a method of antagonizing one or more aspartic acid proteases of a subject in need of antagonizing one or more aspartic acid proteases using such aspartic acid protease inhibitors, and a subject in need of treating aspartic acid protease mediated disorder. A method for treating aspartic acid protease mediated disorders. |